Comparable stake leader
BlackRock, Inc.
SEC ownership of ARVINAS, INC.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001655759.
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
31 Mar 2026
- Public ticker
- ARVN on Nasdaq
- Parsed ownership sources
- 13F, 13D/G, and 3/4/5
- Largest SEC-reported holder
- BlackRock, Inc.
- Latest 13D/G holder
- BlackRock, Inc.
- Latest parsed ownership date
- 31 Mar 2026
- Issuer CIK
- 0001655759
- Issuer location
- New Haven, CT
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of ARVINAS, INC. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
31 Mar 2026
13F
13D/G
3/4/5
Lead comparable stake: 7.9%
13D/G row: BlackRock, Inc.
Showing 1-8 of 50 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 7.9%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock, Inc.
7.9%
VANGUARD PORTFOLIO MANAGEMENT LLC
6.1%
D. E. SHAW & CO, L.P.
5.3%
Logos Global Management LP
3.4%
PRICE T ROWE ASSOCIATES INC /MD/
1.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
Company
|
7.9%
from 13D/G
|
$72,054,389
6,797,584 shares
|
— | 31 Mar 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC |
13D/G
13F
Vanguard Portfolio Management · Company
|
6.1%
|
$41,527,313
3,917,671 shares
|
$0 | 31 Mar 2026 |
| D. E. SHAW & CO, L.P. |
13D/G
|
5.3%
|
$29,010,822
3,405,026 shares
|
$0 | 06 Nov 2025 |
| Logos Global Management LP |
13D/G
|
3.4%
|
$21,300,000
2,500,000 shares
|
-$32,376,000 | 13 Oct 2025 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13D/G
13F
T. Rowe Price Associates, Inc. · Company
|
1.9%
|
$10,605,117
1,333,977 shares
|
$0 | 30 Jun 2025 |
| CITADEL ADVISORS LLC |
13F
13D/G
Company · Kenneth Griffin
|
0.4%
from 13D/G
|
$12,518,472
1,180,988 shares
|
— | 31 Mar 2026 |
| John G. Houston |
3/4/5
Director
|
1.8%
|
$14,745,484
1,122,183 shares
|
-$466,154 | 27 Feb 2026 |
| D. E. Shaw & Co., Inc. |
13F
Company
|
5.7%
|
$38,568,810
3,638,567 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$922,768.
Buys
$495,080
Insiders: 1
Sells
$1,417,848
Insiders: 6
Net
-$922,768
Shares: -76,267
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 50,000
Shares: 126,267
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 20,000 | 52,124 | $268,070 | $523,471 | -$255,401 |
| 3-6 | 0 | 65,630 | $0 | $829,379 | -$829,379 |
| 6-9 | 30,000 | 230 | $227,010 | $2,275 | +$224,735 |
| 9-12 | 0 | 8,283 | $0 | $62,724 | -$62,724 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 21 reporting-owner rows connected to ARVINAS, INC.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
21
Largest Forms 3/4/5 holder
John G. Houston
Net 12M change
-$922,768
Latest report
21 May 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| John G. Houston | Director | $14,745,484 | -$466,154 | -3.1% | Filing P/S | 27 Feb 2026 |
| Sean A. Cassidy | Chief Financial Officer | $8,559,148 | Filing P/S | 23 Feb 2024 | ||
| Ronald Peck | Chief Medical Officer | $4,106,228 | Mixed | 23 Feb 2024 | ||
| Noah Berkowitz | Chief Medical Officer | $3,251,248 | -$249,410 | -7.1% | Mixed | 11 May 2026 |
| Ian Taylor | President, R&D | $3,137,181 | Mixed | 24 Feb 2025 | ||
| Andrew Saik | Chief Financial Officer | $3,118,550 | -$215,113 | -6.5% | Mixed | 11 May 2026 |
| Angela M. Cacace | Chief Scientific Officer | $3,017,566 | -$213,796 | -6.6% | Mixed | 11 May 2026 |
| Randy Teel | President and CEO, Director | $2,575,483 | -$226,477 | -8.1% | Filing P/S | 21 May 2026 |
| Briggs Morrison | Director | $1,432,137 | +$495,080 | +53% | Mixed | 06 Mar 2026 |
| David K. Loomis | VP, Chief Accounting Officer | $658,229 | -$46,898 | -6.7% | Mixed | 11 May 2026 |
| Edward Moore Kennedy Jr. | Director | $590,016 | Mixed | 25 Jun 2025 | ||
| Wendy L. Dixon | Director | $350,528 | Mixed | 15 Jun 2023 | ||
| Sunil Agarwal | Director | $340,294 | Mixed | 25 Jun 2025 | ||
| Laurie Smaldone Alsup | Director | $313,631 | Mixed | 25 Jun 2025 | ||
| Linda Bain | Director | $313,631 | Mixed | 25 Jun 2025 | ||
| Everett Cunningham | Director | $313,631 | Mixed | 25 Jun 2025 | ||
| John D. Young | Director | $313,631 | Mixed | 25 Jun 2025 | ||
| Leslie Norwalk V | Director | $313,631 | Mixed | 25 Jun 2025 | ||
| Liam Ratcliffe | Director | $163,072 | Mixed | 16 Jun 2022 | ||
| Timothy M. Shannon | Director | $163,072 | Mixed | 16 Jun 2022 |
Recent insider transactions for ARVINAS, INC.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Randy Teel | ARVN | Common Stock | Sale | -0.77% | $19,962 | $9.04 | -2,209 | 285,009 | 21 May 2026 | Direct |
| Andrew Saik | ARVN | Common Stock | Sale | -5.45% | $110,693 | $9.94 | -11,139 | 193,128 | 11 May 2026 | Direct |
| David K. Loomis | ARVN | Common Stock | Sale | -4.56% | $19,070 | $9.94 | -1,919 | 40,193 | 11 May 2026 | Direct |
| Angela M. Cacace | ARVN | Common Stock | Sale | -5.01% | $95,965 | $9.94 | -9,657 | 182,966 | 11 May 2026 | Direct |
| Noah Berkowitz | ARVN | Common Stock | Sale | -5.49% | $110,385 | $9.94 | -11,108 | 191,395 | 11 May 2026 | Direct |
| Randy Teel | ARVN | Common Stock | Sale | -3.25% | $95,965 | $9.94 | -9,657 | 287,218 | 11 May 2026 | Direct |
| Noah Berkowitz | ARVN | Common Stock | Sale | -3.08% | $71,431 | $11.10 | -6,435 | 202,503 | 18 Mar 2026 | Direct |
| Briggs Morrison | ARVN | Common Stock | Purchase | 26.3% | $268,070 | $13.40 | 20,000 | 96,021 | 06 Mar 2026 | Direct |
| John G. Houston | ARVN | Common Stock | Sale | -3.05% | $466,154 | $13.21 | -35,297 | 1,122,183 | 27 Feb 2026 | Direct |
| Randy Teel | ARVN | Common Stock | Award | 98.3% | 147,179 | 296,875 | 26 Feb 2026 | Direct | ||
| David K. Loomis | ARVN | Common Stock | Award | 41.8% | 12,420 | 42,112 | 26 Feb 2026 | Direct | ||
| David K. Loomis | ARVN | Stock Option (right to buy) | Award | 18,504 | 18,504 | 26 Feb 2026 | Direct | |||
| Angela M. Cacace | ARVN | Common Stock | Award | 30.5% | 45,000 | 192,623 | 26 Feb 2026 | Direct | ||
| Angela M. Cacace | ARVN | Stock Option (right to buy) | Award | 67,000 | 67,000 | 26 Feb 2026 | Direct | |||
| Noah Berkowitz | ARVN | Common Stock | Award | 27.4% | 45,000 | 208,938 | 26 Feb 2026 | Direct | ||
| Noah Berkowitz | ARVN | Stock Option (right to buy) | Award | 67,000 | 67,000 | 26 Feb 2026 | Direct | |||
| Andrew Saik | ARVN | Common Stock | Award | 28.2% | 45,000 | 204,267 | 26 Feb 2026 | Direct | ||
| Andrew Saik | ARVN | Stock Option (right to buy) | Award | 67,000 | 67,000 | 26 Feb 2026 | Direct | |||
| David K. Loomis | ARVN | Common Stock | Sale | -3.6% | $13,473 | $12.16 | -1,108 | 29,692 | 23 Feb 2026 | Direct |
| Angela M. Cacace | ARVN | Common Stock | Sale | -2.39% | $43,885 | $12.16 | -3,609 | 147,623 | 23 Feb 2026 | Direct |
| Randy Teel | ARVN | Common Stock | Sale | -3.1% | $58,198 | $12.16 | -4,786 | 149,696 | 23 Feb 2026 | Direct |
| Randy Teel | ARVN | Common Stock | Sale | -2.77% | $52,352 | $11.89 | -4,403 | 154,482 | 13 Feb 2026 | Direct |
| Andrew Saik | ARVN | Common Stock | Sale | -3.12% | $61,043 | $11.89 | -5,134 | 159,267 | 13 Feb 2026 | Direct |
| Angela M. Cacace | ARVN | Common Stock | Sale | -2.95% | $54,599 | $11.89 | -4,592 | 151,232 | 13 Feb 2026 | Direct |
| Noah Berkowitz | ARVN | Common Stock | Sale | -3.35% | $67,595 | $11.89 | -5,685 | 163,938 | 13 Feb 2026 | Direct |
| David K. Loomis | ARVN | Common Stock | Sale | -3.19% | $12,080 | $11.89 | -1,016 | 30,800 | 13 Feb 2026 | Direct |
| David K. Loomis | ARVN | Common Stock | Sale | -0.72% | $2,275 | $9.89 | -230 | 31,697 | 07 Nov 2025 | Direct |
| Briggs Morrison | ARVN | Common Stock | Purchase | 65.2% | $227,010 | $7.57 | 30,000 | 76,021 | 22 Sep 2025 | Direct |
| Sunil Agarwal | ARVN | Common Stock | Award | 113.3% | 16,025 | 30,166 | 25 Jun 2025 | Direct | ||
| Sunil Agarwal | ARVN | Stock Option (right to buy) | Award | 23,105 | 23,105 | 25 Jun 2025 | Direct | |||
| Laurie Smaldone Alsup | ARVN | Common Stock | Award | 159.9% | 16,025 | 26,045 | 25 Jun 2025 | Direct | ||
| Laurie Smaldone Alsup | ARVN | Stock Option (right to buy) | Award | 23,105 | 23,105 | 25 Jun 2025 | Direct | |||
| Briggs Morrison | ARVN | Common Stock | Award | 53.4% | 16,025 | 46,021 | 25 Jun 2025 | Direct | ||
| Briggs Morrison | ARVN | Stock Option (right to buy) | Award | 23,105 | 23,105 | 25 Jun 2025 | Direct | |||
| John D. Young | ARVN | Common Stock | Award | 159.9% | 16,025 | 26,045 | 25 Jun 2025 | Direct | ||
| John D. Young | ARVN | Stock Option (right to buy) | Award | 23,105 | 23,105 | 25 Jun 2025 | Direct | |||
| Linda Bain | ARVN | Common Stock | Award | 159.9% | 16,025 | 26,045 | 25 Jun 2025 | Direct | ||
| Linda Bain | ARVN | Stock Option (right to buy) | Award | 23,105 | 23,105 | 25 Jun 2025 | Direct | |||
| Edward Moore Kennedy Jr. | ARVN | Common Stock | Award | 68.5% | 16,025 | 39,430 | 25 Jun 2025 | Direct | ||
| Edward Moore Kennedy Jr. | ARVN | Stock Option (right to buy) | Award | 23,105 | 23,105 | 25 Jun 2025 | Direct | |||
| Everett Cunningham | ARVN | Common Stock | Award | 159.9% | 16,025 | 26,045 | 25 Jun 2025 | Direct | ||
| Everett Cunningham | ARVN | Stock Option (right to buy) | Award | 23,105 | 23,105 | 25 Jun 2025 | Direct | |||
| Leslie Norwalk V | ARVN | Common Stock | Award | 159.9% | 16,025 | 26,045 | 25 Jun 2025 | Direct | ||
| Leslie Norwalk V | ARVN | Stock Option (right to buy) | Award | 23,105 | 23,105 | 25 Jun 2025 | Direct | |||
| Andrew Saik | ARVN | Common Stock | Sale | -3.35% | $43,377 | $7.61 | -5,700 | 164,401 | 24 Jun 2025 | Direct |
| Angela M. Cacace | ARVN | Common Stock | Sale | -1.65% | $19,347 | $7.49 | -2,583 | 154,248 | 17 Jun 2025 | Direct |
* marks a reported price that did not pass the local price check.